FDA Recalls Menthol Medicated Patches Due to Manufacturing Deviations
FDA recalls THERA CARE COLD HOT MEDICATED PATCH (menthol 5%) due to manufacturing practice deviations. The voluntary recall affects 279,936 patches distributed nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a voluntary, precautionary FDA Class II recall with no reported illnesses or injuries. The hazard involves manufacturing process deviations rather than a specific product contamination, and no health impacts have been documented.
Plain-English summary
THERA CARE COLD HOT MEDICATED PATCH, containing 5% menthol, is a topical over-the-counter drug product manufactured by Unexo Life Sciences Private Limited for Veridian Healthcare, LLC. The product is packaged with 5 patches per box. Approximately 279,936 patches have been affected by this recall and were distributed nationwide in the United States.
The FDA initiated this Class II recall due to current good manufacturing practice (cGMP) deviations identified at the manufacturing facility. cGMP violations indicate the manufacturer did not follow FDA-required standards for drug manufacturing processes.
Consumers can identify affected product using the UPC code 8 45717 00818 1 and NDC number 71101-954-05. The manufacturer voluntarily initiated the recall on October 24, 2024. The recall was terminated by the FDA on September 16, 2025.
The recalled product
- Product
- THERA CARE COLD HOT MEDICATED PATCH (MENTHOL)
- Brand
- THERA CARE COLD HOT MEDICATED PATCH
- Manufacturer
- Unexo Life Sciences Private Limited
- Category
- Drug — Topical Over-the-Counter
- Hazard
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UPC 8 45717 00818 1
UPCs (2)
- 0845717008181
- 845717008181
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27